REVB

REVELATION BIOSCIENCES, INC. REVB

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-3.32M

Quarter to Jun 30

Free cash flow

$-2.60M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$313.2K total
SABBY MANAGEMENT, LLC
$216.9K+111.8%
CITADEL ADVISORS LLC
$39.7KNew
GEODE CAPITAL MANAGEMENT, LLC
$17.7K-60.2%
HRT FINANCIAL LP
$17.0KNew
VANGUARD FIDUCIARY TRUST CO
$13.5K0.0%
Tower Research Capital LLC (TRC)
$6.7K+60.2%
ROYAL BANK OF CANADA
$1.0K0.0%
SBI Securities Co., Ltd.
$3540.0%
BARCLAYS PLC
$173New
HARBOUR INVESTMENTS, INC.
$420.0%
BNP Paribas Asset Management Holding S.A.
$90.0%
Caitong International Asset Management Co., Ltd
$10.0%
FMR LLC
$0New
See all 13 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/REVB

Earnings Per Share

13fpro.ai/company/REVB

Loading ratio trend…

REVB insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About REVELATION BIOSCIENCES, INC. (REVB): stock profile, AI score and financials

REVELATION BIOSCIENCES, INC. (REVB) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. REVB is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), REVELATION BIOSCIENCES, INC. reports net income of $-3.3M, free cash flow of $-2.6M. Top institutional holders of REVB by reported 13-F value include SABBY MANAGEMENT, CITADEL ADVISORS, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. REVB trades on the Nasdaq exchange and files with the SEC under CIK 1810560. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate REVB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for REVELATION BIOSCIENCES, INC. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1810560 →